PRECIGEN INC
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of and
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | March 31,2024 | December 31,2023 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $17,478 | $7,578 |
| Short-term investments | 27,280 | 55,277 |
| Receivables | ||
| Trade, less allowance for credit losses of $0 and $184 as of March 31, 2024 and December 31, 2023 | 872 | 902 |
| Other | 290 | 673 |
| Prepaid expenses and other | 3,626 | 4,325 |
| Total current assets | 49,546 | 68,755 |
| Property, plant and equipment, net | 12,620 | 7,111 |
| Intangible assets, net | 38,717 | 40,701 |
| Goodwill | 26,555 | 26,612 |
| Right-of-use assets | 6,658 | 7,097 |
| Other assets | 751 | 767 |
| Total assets | $134,847 | $151,043 |
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | March 31,2024 | December 31,2023 |
|---|---|---|
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $4,716 | $1,726 |
| Accrued compensation and benefits | 9,962 | 8,250 |
| Other accrued liabilities | 7,296 | 6,223 |
| Settlement and indemnification accruals | 5,075 | 5,075 |
| Deferred revenue | 407 | 509 |
| Current portion of lease liabilities | 1,318 | 1,202 |
| Total current liabilities | 28,774 | 22,985 |
| Deferred revenue, net of current portion | 1,888 | 1,818 |
| Lease liabilities, net of current portion | 5,387 | 5,895 |
| Deferred tax liabilities | 1,779 | 1,847 |
| Total liabilities | 37,828 | 32,545 |
| Commitments and contingencies (Note 13) | ||
| Shareholders' equity | ||
| Common stock, no par value, 400,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 256,398,527 shares issued as of March 31, 2024 and December 31, 2023, 250,248,808 shares and 248,919,096 shares outstanding as of March 31, 2024 and December 31, 2023, respectively. | — | — |
| Additional paid-in capital | 2,088,025 | 2,084,916 |
| Accumulated deficit | (1,988,209) | (1,964,471) |
| Accumulated other comprehensive loss | (2,797) | (1,947) |
| Total shareholders' equity | 97,019 | 118,498 |
| Total liabilities and shareholders' equity | $134,847 | $151,043 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.